| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |